Infectious Disease Diagnostics Market Report | Covid-19 Impact Analysis

This report, from Stratview Research, studies the clinical diagnostics market - infectious diesease diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

The Burning Questions This Report Will Answer:

1. Which diagnostic segments are more attractive in the US and Europe? Is it equally attractive in Africa and the Middle East?
2. Why specificity and sensitivity of tests are always a concern for the treating physician?
3. Is the demand for infectious disease testing uniform across the globe? Which are the major centres which consume maximum reagents and kits to diagnose?
4. Are these tests covered under health insurance?

The Global Clinical Diagnostics Market – Infectious Disease Diagnostics: Highlights

New tests are always needed that can identify a specific pathogen or at a minimum, distinguish between bacterial and viral infections, and provide information on susceptibility to antimicrobial agents. Tests should be easy to use and provide a rapid result (ideally within an hour) to have a positive impact on care. The infectious diseases physician can serve as a bridge between the laboratory and the healthcare provider to ensure the proper use and interpretation of diagnostic testing. The expertise of the infectious diseases clinician becomes more important with the advent of newer, more complex tests. The availability of laboratory tests and POC (bedside) determines the improvements in clinical outcomes for patients, antimicrobial stewardship, detection and tracking of disease outbreaks, and investigation of unknown pathogens in all major markets.

The key players in the global market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMerieux (France), Bio-Rad (US), and Roche (Switzerland) while regional players in vary from Danaher Corporation, Becton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Alere Inc., DiaSorin S.p.A., Quidel Corporation, besides the global players.

Research Methodology

Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, Product portfolio, New launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors 
• Future outlook

The global clinical diagnostics market (infectious disease diagnostics) is segmented into the following categories: 

By Product & Service

• Assay, Kit & Reagent, Instruments

By Indication

• Hepatitis, HIV, HAI, HPV, TB, Influenza, Other Infectious Diseases

By Technology

• Immunodiagnostics, PCR, NGS, Other testing methods

By Testing Facility

• Hospital Laboratories, Diagnostic Clinics, Mobile Clinics, Others

By Region

• North America (Country Analysis: the USA, Canada)
• Western Europe (Country Analysis: Germany, France, the UK)
• Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
• Latin America (Country Analysis: Brazil, Argentina, Mexico, and Others)
• Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others) 

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:

Company Profiling

• SWOT analysis of key players (up to 3 players)
• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].